Two large clinical trials presented at this year’s annual ASCO meeting demonstrated that adding the hormone-blocking drug abiraterone to androgen-deprivation therapy (ADT) allowed men with metastatic hormone-sensitive prostate cancer to live longer than men who were treated with ADT alone.
Findings from a large international clinical trial suggest that 3 months of chemotherapy after surgery for advanced colon cancer may be just as good as 6 months for patients at low risk of disease recurrence.
This ongoing clinical trial is enrolling patients with newly diagnosed metastatic non-small cell lung cancer that tests positive for a mutation in the EGFR gene. Doctors want to know if combining afatinib (Gilotrif®) with cetuximab (Erbitux®) improves survival better than afatinib alone for these patients.
As patients think about taking part in a clinical trial, they will face the issue of how to cover the costs of care. Learn who is expected to pay for which costs in a cancer clinical trial, as well as tips for working with insurance companies.
Federal law requires most health insurance plans to cover routine patient care costs in clinical trials under certain conditions. Learn which types of trials are covered and specific types of cost that are not.
NCI-Supported Clinical Trials that Are Recruiting Patients
This phase 1 trial studies the side effects and best doses of cabozantinib and nivolumab with or without ipilimumab in treating patients with genitourinary (genital and urinary organ) tumors that have spread to other places in the body.
This phase 3 trial tests how well gemcitabine hydrochloride and cisplatin with or without radiation therapy work in treating patients with localized liver cancer that cannot be removed by surgery.
This phase 2 clinical trial studies how well heated intraperitoneal chemotherapy and surgery work in treating patients with stomach cancer that has spread to the peritoneum, the tissue that lines the wall of the abdomen and abdominal organs.
